|
1
|
Nezu M, Souma T, Yu L, Suzuki T, Saigusa
D, Ito S, Suzuki N and Yamamoto M: Transcription factor Nrf2
hyperactivation in early-phase renal ischemia-reperfusion injury
prevents tubular damage progression. Kidney Int. 91:387–401. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Malek M and Nematbakhsh M: Renal
ischemia/reperfusion injury; from pathophysiology to treatment. J
Renal Inj Prev. 4:20–27. 2015.PubMed/NCBI
|
|
3
|
Zhu J, Chen X, Wang H and Yan Q: Catalpol
protects mice against renal ischemia/reperfusion injury via
suppressing PI3K/Akt-eNOS signaling and inflammation. Int J Clin
Exp Med. 8:2038–2044. 2015.PubMed/NCBI
|
|
4
|
Kim N, Woo DC, Joo SJ, Song Y, Lee JJ, Woo
CW, Kim ST, Hong S, Cho YM and Han DJ: Reduction in renal
ischemia-reperfusion injury in mice by a phosphoinositide 3-kinase
p110gamma-specific inhibitor. Transplantation. 99:2070–2076. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meng QH, Liu HB and Wang JB: Polydatin
ameliorates renal ischemia/reperfusion injury by decreasing
apoptosis and oxidative stress through activating sonic hedgehog
signaling pathway. Food Chem Toxicol. 96:215–225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ozbilgin S, Ozkardesler S, Akan M, Boztas
N, Ozbilgin M, Ergur BU, Derici S, Guneli ME and Meseri R: Renal
ischemia/reperfusion injury in diabetic rats: The role of local
ischemic preconditioning. Biomed Res Int. 2016:85804752016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Akan M, Ozbilgin S, Boztas N, Celik A,
Ozkardesler S, Ergur BU, Guneli E, Sisman AR, Akokay P and Meseri
R: Effect of magnesium sulfate on renal ischemia-reperfusion injury
in streptozotocin-induced diabetic rats. Eur Rev Med Pharmacol Sci.
20:1642–1655. 2016.PubMed/NCBI
|
|
8
|
Wu SH, Chen XQ, Lü J and Wang MJ: BML-111
Attenuates renal ischemia/reperfusion injury via peroxisome
proliferator-activated receptor-α-regulated heme oxygenase-1.
Inflammation. 39:611–624. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu D, Jin F, Shu G, Xu X, Qi J, Kang X,
Yu H, Lu K, Jiang S, Han F, et al: Enhanced efficiency of
mitochondria-targeted peptide SS-31 for acute kidney injury by
pH-responsive and AKI-kidney targeted nanopolyplexes. Biomaterials.
211:57–67. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu JB, Li SJ, Kang XQ, Qi J, Wu JH, Wang
XJ, Xu XL, Ying XY, Jiang SP, You J and Du YZ: CD44-targeted
hyaluronic acid-curcumin prodrug protects renal tubular epithelial
cell survival from oxidative stress damage. Carbohydr Polym.
193:268–280. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kimura T, Takabatake Y, Takahashi A,
Kaimori JY, Matsui I, Namba T, Kitamura H, Niimura F, Matsusaka T,
Soga T, et al: Autophagy protects the proximal tubule from
degeneration and acute ischemic injury. J Am Soc Nephrol.
22:902–913. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hamzawy M, Gouda SAA, Rashed L, Morcos MA,
Shoukry H and Sharawy N: 22-oxacalcitriol prevents acute kidney
injury via inhibition of apoptosis and enhancement of autophagy.
Clin Exp Nephrol. 23:43–55. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pang L: Inhibition of COX-2/PGE2/EP4
signaling protects against post-hypoxic apoptosis in H9C2
cardiomyocytes. Faseb J. 30:2016.
|
|
14
|
Xiao CY, Yuhki K, Hara A, Fujino T,
Kuriyama S, Yamada T, Takayama K, Takahata O, Karibe H, Taniguchi
T, et al: Prostaglandin E2 protects the heart from
ischemia-reperfusion injury via its receptor subtype EP4.
Circulation. 109:2462–2468. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang X, Lin L, Woodling NS, Wang Q,
Anacker C, Pan T, Merchant M and Andreasson K: Signaling via the
prostaglandin E2 receptor EP4 exerts neuronal and
vascular protection in a mouse model of cerebral ischemia. J Clin
Invest. 121:4362–4371. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C,
Karasuyama H, Su MS, Rakic P and Flavell RA: Reduced apoptosis and
cytochrome c-mediated caspase activation in mice lacking caspase 9.
Cell. 94:325–337. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wiktorowska-Owczarek A and Owczarek J: The
effect of hypoxia on PGE2-stimulated cAMP generation in HMEC-1.
Cell Mol Biol Lett. 20:213–221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Zhong D, Lei L, Jia Y, Zhou H and
Yang B: Propofol prevents renal ischemia-reperfusion injury via
inhibiting the oxidative stress pathways. Cell Physiol Biochem.
37:14–26. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou S, Sun Y, Zhuang Y, Zhao W and Chen
Y, Jiang B, Guo C, Zhang Z, Peng H and Chen Y: Effects of
kallistatin on oxidative stress and inflammation on renal
ischemia-reperfusion injury in mice. Curr Vasc Pharmacol.
13:265–273. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cursio R, Colosetti P and Gugenheim J:
Autophagy and liver ischemia-reperfusion injury. Biomed Res Int.
2015:4175902015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Decuypere JP, Ceulemans LJ, Agostinis P,
Monbaliu D, Naesens M, Pirenne J and Jochmans I: Autophagy and the
kidney: Implications for ischemia-reperfusion injury and therapy.
Am J Kidney Dis. 66:699–709. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li H, Liu X, Zhu Y, Liu Y and Wang Y:
Magnolol derivative 002C-3 protects brain against
ischemia-reperfusion injury via inhibiting apoptosis and autophagy.
Neurosci Lett. 588:178–183. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qiao PF, Yao L, Zhang XC, Li GD and Wu DQ:
Heat shock pretreatment improves stem cell repair following
ischemia- reperfusion injury via autophagy. World J Gastroenterol.
21:12822–12834. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang M, Liu K, Luo J and Dong Z:
Autophagy is a renoprotective mechanism during in vitro hypoxia and
in vivo ischemia-reperfusion injury. Am J Pathol. 176:1181–1192.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tan KY, Li CY, Li YF, Fei J, Yang B, Fu YJ
and Li F: Real-time monitoring ATP in mitochondrion of living
cells: A specific fluorescent probe for ATP by dual recognition
sites. Anal Chem. 89:1749–1756. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lewis SC, Uchiyama LF and Nunnari J:
ER-mitochondria contacts couple mtDNA synthesis with mitochondrial
division in human cells. Science. 353:aaf55492016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lauritzen KH, Kleppa L, Aronsen JM, Eide
L, Carlsen H, Haugen ØP, Sjaastad I, Klungland A, Rasmussen LJ,
Attramadal H, et al: Impaired dynamics and function of mitochondria
caused by mtDNA toxicity leads to heart failure. Am J Physiol Heart
Circ Physiol. 309:H434–H449. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng N, Lo YS, Ansari MI, Ho KC, Jeng ST,
Lin NS and Dai H: Correlation between mtDNA complexity and mtDNA
replication mode in developing cotyledon mitochondria during mung
bean seed germination. New Phytol. 213:751–763. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hämäläinen RH: Mitochondria and mtDNA
integrity in stem cell function and differentiation. Curr Opin
Genet Dev. 38:83–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Baruffini E, Ferrari J, Dallabona C,
Donnini C and Lodi T: Polymorphisms in DNA polymerase γ affect the
mtDNA stability and the NRTI-induced mitochondrial toxicity in
Saccharomyces cerevisiae. Mitochondrion. 20:52–63. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sokolowska M, Chen LY, Liu Y,
Martinez-Anton A, Qi HY, Logun C, Alsaaty S, Park YH, Kastner DL,
Chae JJ and Shelhamer JH: Prostaglandin E2 inhibits NLRP3
inflammasome activation through EP4 receptor and intracellular cAMP
in human macrophages. J Immunol. 194:5472–5487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang HH, Young SH, Sinnett-Smith J, Chou
CE, Moro A, Hertzer KM, Hines OJ, Rozengurt E and Eibl G:
Prostaglandin E2 activates the mTORC1 pathway through an
EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human
pancreatic carcinoma cell line PANC-1. Am J Physiol Cell Physiol.
309:C639–C649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang HH, Young S, Sinnett-Smith J, Chou
CEN, Hines OJ, Rozengurt E and Eibl G: Abstract 1028: Prostaglandin
E2 activates the mTORC1 pathway through an EP4/cAMP/PKA and
EP1/calcium-mediated mechanisms in human pancreatic carcinoma
cells. Am J Physiol Cell Physiol. 309:2015.
|
|
34
|
Xu S, Ge JP, Zhang ZY and Zhou WQ: AB063.
A prostaglandin E (PGE) receptor EP4 is involved in the cell growth
and invasion of prostate cancer via the cAMP-PKA/PI3K-AKT signaling
pathway. Transl Androl Urol. 6 (Suppl 3):2017. View Article : Google Scholar : PubMed/NCBI
|
